Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other financing activities (2016 - 2021)

Historic Other financing activities for Prestige Consumer Healthcare (PBH) over the last 12 years, with Q1 2021 value amounting to $17.7 million.

  • Prestige Consumer Healthcare's Other financing activities rose 213994.94% to $17.7 million in Q1 2021 from the same period last year, while for Dec 2022 it was $17.7 million, marking a year-over-year decrease of 427.36%. This contributed to the annual value of $769000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Other financing activities of $17.7 million as of Q1 2021, which was up 213994.94% from $791000.0 recorded in Q1 2020.
  • Prestige Consumer Healthcare's 5-year Other financing activities high stood at $17.7 million for Q1 2021, and its period low was -$302000.0 during Q2 2017.
  • For the 4-year period, Prestige Consumer Healthcare's Other financing activities averaged around $5.2 million, with its median value being $880500.0 (2018).
  • Per our database at Business Quant, Prestige Consumer Healthcare's Other financing activities crashed by 9187.6% in 2018 and then soared by 213994.94% in 2021.
  • Prestige Consumer Healthcare's Other financing activities (Quarter) stood at -$168000.0 in 2017, then soared by 677.38% to $970000.0 in 2018, then fell by 18.45% to $791000.0 in 2020, then skyrocketed by 2139.95% to $17.7 million in 2021.
  • Its Other financing activities stands at $17.7 million for Q1 2021, versus $791000.0 for Q1 2020 and $970000.0 for Q1 2018.